Gene Therapy Department - University of North Carolina at Chapel Hill
 
Research
    Samulski Lab
    Kafri Lab
    Monahan Lab
    McCown Lab
Vector Core Facilities
    Services
    MTA
    Clinical Wing
    Research Wing
Clinical Trials
Administration
    Directors Offices
    Employment
    Contributions
Strategic Partners
    Asklepios
    MDA
    Duke University
    Robert Wood Johnson
    Ohio State University
    University of Pittsburgh
Gene Therapy Links
 
 

Research Wing

Laboratory Director: Xing-hua Zeng

Technical Staff:
 
Svetlana Averianova
Ying Shi
Danielle Lungelow

 

Research-Grade Manufacturing & Testing Services


Research-grade materials are produced in a 2040 sq. ft. facility that consists of six separate laboratory rooms, an equipment room, a cold room, a materials storage room and an administrative office.  Access to the facility is controlled by lock and key and is limited to authorized personnel.  The facilities have separate rooms for producing various types of vector platforms including AAV, Adenovirus, Lentivirus, Retrovirus and cell-based products.  The facilities are also used for process development, Quality Control assays and manufacturing of bacterial products under cGMP.

The procedures used in the Research Wing are integrated into the Standard Operating Procedures (SOPs) and Qualilty Control systems used for clinical manufacturing.  This control infrastructure allows additional quality control mechanisms to be readily applied if a higher level of characterization or documentation is desired for a specific product.  Applying control mechanisms in a logical manner to match the grade of the materials serves to enhance the overall quality and lot-to-lot consistency of research and pre-clinical materials.  A complete list of the SOPs and Quality Systems used by the JVL are provided online.      

 

Research-Grade Vectors

  • Small, standard sized preparations of research grade material for set price
  • Provided with a guarantee of purity and titer within specified ranges
  • The facility can produce AAV, Adenovirus, Lentivirus and plasmid vectors
  • Aliquots of GFP, luciferase or LacZ control vectors are also available

Pre-Clinical-Grade Vectors  

  • Large-scale preps for formal Pharm/Tox and Bio-distribution studies
  • Manufactured following the cGMP guidelines
  • More extensive lot release criteria and testing specifications
  • Investigators are provided with a Pre-Clinical Material CMC Report
  • Priced individually on the basis of pilot lots to determine vector yield
  • Can be customized


Process Development Projects

  • Manufacturing and purification procedures for AAV production in Baculovirus
  • Developing large-scale production capacity for AAV serotypes 1-8
  • QC assay development for AAV, Adenovirus and Lentivirus.

 

UNC Gene Therapy Center Contact Information
Gene Therapy Center Home University of North Carolina at Chapel Hill Contact the Gene Therapy Center